Pegsunercept
Jump to navigation
Jump to search
Template:Short description Template:Drugbox Pegsunercept is a drug for the treatment of rheumatoid arthritis. As of January 2010[update]Script error: No such module "Check for unknown parameters"., Phase II clinical trials have been completed.[1][2][3] It is being developed by Amgen.
Similarly to etanercept, pegsunercept is a soluble tumor necrosis factor receptor. Pegsunercept is a PEGylated protein.[3]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Clinical trial number NCT00037700 for "Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis" at ClinicalTrials.gov
- ↑ Clinical trial number NCT00111423 for "Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)" at ClinicalTrials.gov
- ↑ a b Script error: No such module "Citation/CS1".
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox". Template:Cytokine receptor modulators